Stryker faces two new investigations

Devicemaker Stryker Corp. has been targeted by two investigations, one looking at its relationship with doctors, and the other related to compliance issues regarding one of its products.

For one thing, Stryker has gotten a subpoena from the office of New Jersey attorney general Anne Milgram, who wants to know more about its financial interest in and compensation of doctors participating in some clinical trials of its products. Stryker also faces an inquiry from the FDA related to compliance on its craniomaxillofacial implant product.

Clearly, the New Jersey AG is on the warpath where devicemakers are concerned. The agreement comes only two days after she reached a voluntary compliance agreement with spinal devicemaker Synthes over the way it paid doctors participating in clinical trials.

Milgram has let it be known that her office also plans to send subpoenas to five other devicemakers, requesting similar data on relationships with doctors. Meanwhile, a handful of other devicemakers in addition to Stryker have received subpoenas as well.

To learn more about Stryker's woes:
- read this Modern Healthcare piece (reg. req.)

Related Articles:
Orthopedic surgeons receiving kickbacks?
Group says YouTube medical device ads may be illegal

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.